Filter
284
Text search:
substandard
medicines
Featured
Recommendations
23
New Publications
100
Language
Document type
No document type
154
Studies & Reports
55
Guidelines
30
Strategic & Response Plan
18
Manuals
12
Fact sheets
5
Training Material
4
Situation Updates
4
Infographics
2
Countries / Regions
Kenya
13
Western and Central Europe
10
Uganda
9
Malawi
9
Ethiopia
8
India
8
Global
8
Nigeria
7
Sierra Leone
6
Tanzania
6
Rwanda
6
Liberia
5
Zambia
5
Myanmar / Burma
5
Ghana
4
Nepal
4
Syria
4
Cambodia
4
Bangladesh
4
Eswatini/ Swaziland
4
South–East Asia Region
4
Africa
4
Congo, Democratic Republic of
3
Zimbabwe
3
Namibia
3
Cameroon
2
Haiti
2
Philippines
2
Pakistan
2
Thailand
2
South Africa
2
Mozambique
2
Lesotho
2
Latin America and the Carribbean
2
Asia
2
Guinea
1
Jordan
1
Lebanon
1
Indonesia
1
Sudan
1
Central African Republic
1
North Macedonia
1
Ukraine
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Poland
1
Palestine
1
Laos
1
Canada
1
Vietnam
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
111
Public Health
18
Clinical Guidelines
18
Pharmacy & Technologies
10
Key Resources
5
Women & Child Health
3
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
AMR
51
Pharmacy
31
TB
26
HIV
12
COVID-19
10
Global Health Education
7
Conflict
6
Rapid Response
5
Planetary Health
5
Ebola
4
Refugee
4
Mental Health
4
Disability
2
Polio
2
NTDs
2
Specific Hazards
1
Caregiver
1
Health Financing Toolbox
1
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However,
...
Two test methods on dexamethasone tablets and injections
Annex 5, WHO Technical Report Series 1010, 2018
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and acces
...
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
100 test methods for 100 active pharmaceutical ingredients
For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (
...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically
...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid,
...
